John D Scandling
Overview
Explore the profile of John D Scandling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu K, Dor A, Mohanty S, Han J, Parvathinathan G, Braggs-Gresham J, et al.
Med Care
. 2024 Jun;
62(8):521-529.
PMID: 38889200
Background: Recent efforts to increase access to kidney transplant (KTx) in the United States include increasing referrals to transplant programs, leading to more pretransplant services. Transplant programs reconcile the costs...
2.
Abdellatif A, Zhao L, Chamberlain J, Cherny K, Xin Y, Marder B, et al.
Clin Transplant
. 2023 May;
37(9):e14993.
PMID: 37138473
Introduction: Kidney transplant (KT) recipients have a high prevalence and severity of gout. Pegloticase (pegylated recombinant uricase) rapidly metabolizes serum uric acid (sUA), and its efficacy is not impacted by...
3.
Wang A, Busque S, Kuo J, Singh U, Roeltgen K, Pinsky B, et al.
Kidney360
. 2022 Apr;
3(1):133-143.
PMID: 35368573
Background: Morbidity and mortality associated with coronavirus disease 2019 (COVID-19) infection in kidney transplant recipients are high and early outpatient interventions to prevent progression to severe disease are needed. SARS-CoV-2...
4.
Cheng X, Han J, Braggs-Gresham J, Held P, Busque S, Roberts J, et al.
JAMA Netw Open
. 2022 Mar;
5(3):e221847.
PMID: 35267033
Importance: While recent policy reforms aim to improve access to kidney transplantation for patients with end-stage kidney disease, the cost implications of kidney waiting list expansion are not well understood....
5.
Fehr T, Hubel K, de Rougemont O, Abela I, Gaspert A, Gungor T, et al.
Front Immunol
. 2022 Feb;
13:796456.
PMID: 35173720
Induction of immunological tolerance has been the holy grail of transplantation immunology for decades. The only successful approach to achieve it in patients has been a combined kidney and hematopoietic...
6.
Jensen K, Hongo D, Ji X, Zheng P, Pawar R, Wu T, et al.
Blood Adv
. 2021 Aug;
5(17):3290-3302.
PMID: 34432869
Replacement of failed organs followed by safe withdrawal of immunosuppressive drugs has long been the goal of organ transplantation. We studied changes in the balance of T cells and myeloid...
7.
Cosimi A, Ascher N, Emond J, Kaufman D, Madsen J, Miller J, et al.
Transplantation
. 2021 Apr;
105(5):935-940.
PMID: 33901128
No abstract available.
8.
Cheng X, Held P, Dor A, Bragg-Gresham J, Tan J, Scandling J, et al.
Am J Transplant
. 2021 Apr;
21(11):3694-3703.
PMID: 33884757
A potential solution to the deceased donor organ shortage is to expand donor acceptability criteria. The procurement cost implications of using nonstandard donors is unknown. Using 5 years of US...
9.
10.